| 000 | 01373 a2200421 4500 | ||
|---|---|---|---|
| 005 | 20250517064942.0 | ||
| 264 | 0 | _c20161214 | |
| 008 | 201612s 0 0 eng d | ||
| 022 | _a1936-2625 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aXue, Yao | |
| 245 | 0 | 0 |
_aCCND1 G870A polymorphism is associated with toxicity of methotrexate in childhood acute lymphoblastic leukemia. _h[electronic resource] |
| 260 |
_bInternational journal of clinical and experimental pathology _c2015 |
||
| 300 |
_a11594-600 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAlleles |
| 650 | 0 | 4 | _aAmino Acid Substitution |
| 650 | 0 | 4 | _aChild |
| 650 | 0 | 4 | _aChild, Preschool |
| 650 | 0 | 4 |
_aCyclin D1 _xgenetics |
| 650 | 0 | 4 | _aDrug Resistance, Neoplasm |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aGenotype |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLiver _xdrug effects |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMethotrexate _xadverse effects |
| 650 | 0 | 4 | _aMutation |
| 650 | 0 | 4 | _aOdds Ratio |
| 650 | 0 | 4 |
_aPolymorphism, Genetic _xgenetics |
| 650 | 0 | 4 |
_aPrecursor Cell Lymphoblastic Leukemia-Lymphoma _xdrug therapy |
| 700 | 1 | _aRong, Liucheng | |
| 700 | 1 | _aTong, Na | |
| 700 | 1 | _aWang, Meilin | |
| 700 | 1 | _aZhang, Zhengdong | |
| 700 | 1 | _aFang, Yongjun | |
| 773 | 0 |
_tInternational journal of clinical and experimental pathology _gvol. 8 _gno. 9 _gp. 11594-600 |
|
| 999 |
_c25496146 _d25496146 |
||